Pembrolizumab for Early Triple-Negative Breast CancerPeter Schmid, Joyce O’Shaughnessy, Masato Takahashi et al.|New England Journal of Medicine|2020Cited by 3.1k
External Evaluation of 3 Commercial Artificial Intelligence Algorithms for Independent Assessment of Screening MammogramsMattie Salim, Fredrik Strand, Erik Wåhlin et al.|JAMA Oncology|2020Cited by 284
FXYD3 functionally demarcates an ancestral breast cancer stem cell subpopulation with features of drug-tolerant persistersMengjiao Li, Noriko Gotoh, Tatsunori Nishimura et al.|Journal of Clinical Investigation|2023Cited by 29
Axillary evaluation in ductal cancer <i>in situ</i> of the breast: challenging the diagnostic accuracy of clinical practice guidelinesAndreas Karakatsanis, Peter Stålberg, Petros Charalampoudis et al.|British journal of surgery|2021Cited by 3
Prognostic and predictive implications of sterile alpha motif and <scp>HD</scp> domain‐containing protein 1 (<scp>SAMHD1</scp>) expression in breast cancerMaria A. Kouvaraki, Theodoros Foukakis|International Journal of Cancer|2024Cited by 2